Table 3.
CP patients | Controls | ||||
---|---|---|---|---|---|
VDR genotypes | N | % | N | % | p |
TT | 10 | 16.3 | 7 | 15.5 | |
GT | 43 | 70.4 | 33 | 73.3 | 0.939 |
GG | 8 | 13.1 | 5 | 11.1 | |
Total | 61 | 57.5 | 45 | 42.4 |
The level of significance (p<0.05).
CP patients | Controls | ||||
---|---|---|---|---|---|
VDR genotypes | N | % | N | % | p |
TT | 10 | 16.3 | 7 | 15.5 | |
GT | 43 | 70.4 | 33 | 73.3 | 0.939 |
GG | 8 | 13.1 | 5 | 11.1 | |
Total | 61 | 57.5 | 45 | 42.4 |
The level of significance (p<0.05).